New Lab at UF's Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research
New Lab at UF’s Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research Share Article Noninvasive cellular and acellular therapies will lead to life-extending medicines and treatments, including post-COVID anti-inflammation therapy. A new partnership between the world’s top university for biotech business incubation and Neobiosis, a global expert in regenerative medicine, may fuel a healthcare revolution. Regenerative therapy holds the promises of lasting health and wellness through FDA-approved practices. Regenerative medicine has the potential to fight dise...
Source: prweb.com